Fertility and Sterility
Volume 94, Issue 6 , Pages 2202-2207, November 2010

Serum antimüllerian hormone concentrations on day 3 of the in vitro fertilization stimulation cycle are predictive of the fertilization, implantation, and pregnancy in polycystic ovary syndrome patients undergoing assisted reproduction

  • Cemil Kaya, M.D.

      Affiliations

    • Department of Obstetrics and Gynecology, Faculty of Medicine, Ufuk University, Ankara, Turkey
    • Corresponding Author InformationReprint requests: Cemil Kaya, M.D., University Hospital, Department of Obstetrics and Gynecology, Ufuk University, Balgat, 312 Ankara, Turkey (FAX: + 90-312-2851158).
  • ,
  • Recai Pabuccu, M.D.

      Affiliations

    • Department of Obstetrics and Gynecology, Faculty of Medicine, Ufuk University, Ankara, Turkey
  • ,
  • Hakan Satıroglu, M.D.

      Affiliations

    • Department of Obstetrics and Gynecology, Faculty of Medicine, Ankara University, Ankara, Turkey

Received 23 July 2009; received in revised form 23 November 2009; accepted 1 December 2009. published online 05 February 2010.

Objective

To determine the possible relationship between serum antimüllerian hormone (AMH) concentrations on day 3 and controlled ovarian stimulation and reproductive outcomes in women with polycystic ovary syndrome.

Design

Prospective, clinical trial.

Setting

University hospital.

Patient(s)

Sixty women with PCOS.

Intervention(s)

Serum concentrations of AMH measured on cycle day 3.

Main Outcome Measure(s)

Clinic pregnancy rate (CPR), implantation rate (IR), and fertilization rate (FR).

Result(s)

The CPR, IR, and FR were markedly different among the day-3 serum AMH groups (low, moderate, and high AMH groups). The CPR were 33.3, 46.1, and 60.0, respectively, in the low, moderate, and high serum AMH groups on day 3. The embryo IR were 18.6, 26.7, and 36.3, respectively. The FR were 54, 68, and 79, respectively. An AMH level ≥3.01 ng/mL was shown to predict FR with a sensitivity of 86.4% and specificity of 75%. An AMH level ≥3.2 ng/mL was shown to predict IR and CPR with sensitivity and specificity of 72.1% and 72.7%, and 75.6% and 77.3%, respectively.

Conclusion(s)

On day 3 of the in vitro fertilization stimulation cycle, serum concentrations of AMH can be used as a marker for ovarian response as well as reproductive outcome in assisted reproductive cycles of PCOS patients.

Key Words: Antimüllerian hormone, assisted reproduction, polycystic ovary syndrome, serum AMH

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 C.K. has nothing to disclose. R.P. has nothing to disclose. H.S. has nothing to disclose.

PII: S0015-0282(09)04137-5

doi:10.1016/j.fertnstert.2009.12.002

Fertility and Sterility
Volume 94, Issue 6 , Pages 2202-2207, November 2010